PepGen Inc. (PEPG)
Craig-Hallum analyst Adam Vogel initiated coverage with a Buy rating on PepGen Inc. on June 16 and set a price target of $11.00. The company’s shares closed last Thursday at $1.79, close to its 52-week low of $1.16.
According to TipRanks.com, Vogel is a 3-star analyst with an average return of 10.1% and a 60.9% success rate. Vogel covers the Healthcare sector, focusing on stocks such as MapLight Therapeutics, Inc., LB Pharmaceuticals, Inc., and Aclaris Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for PepGen Inc. with a $10.29 average price target.
See today’s best-performing stocks on TipRanks >>
